By InvitationNot Applicable

Follow-up Study of ICUS and CCUS Patients

China300 participantsStarted 2011-01-01

Plain-language summary

The proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions has been released by an international consensus group. Based on the criteria, patients with persistent cytopenia could be diagnosed with MDS, CCUS and ICUS. However, the process and outcome of pre-MDS conditions (CCUS, ICUS) is still to be characterized in Chinese population. We design this prospective observational study to explore the disease process and outcome in ICUS and CCUS patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with cytopenia of any degree in one or more lineages: erythrocytes, neutrophils, or platelets. And the cytopenia has to be persistent (≥ 4 months) and lacking minimal diagnostic criteria of MDS. Exclusion Criteria: * Patients with cytopenia which could be explained by any other hematologic or non-hematologic disease.

What they're measuring

Culumative transformation rate

Timeframe: 5 years

Trial details

NCT IDNCT04428489

SponsorThe First Affiliated Hospital of Soochow University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Myelodysplastic Syndromes trials